Mason John, Deitchler Megan, Mathys Ellen, Winichagoon Pattanee, Tuazon Ma Antonia
Department of International Health and Development, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, USA.
Food Nutr Bull. 2004 Mar;25(1):53-78. doi: 10.1177/156482650402500104.
Micronutrient-deficiency control programs have been greatly extended at the national level in the last 10 to 15 years. However, rigorous evaluations of these are scarce, so that conclusions on impact are tentative and based mainly on indirect evidence. The coverage of vitamin A capsule distribution programs has exceeded 70% in most study countries. In countries implementing national iodized salt programs, the coverage reaches 60% to 90% of households with adequately iodized salt. Of the three micronutrients, coverage of iron tablet supplementation is the least well documented due to inadequate program monitoring systems and population survey data. Supplementation of preschool children 6 to 59 months of age with vitamin A capsules has plausibly contributed to the reduction in clinical vitamin A deficiency and its near-elimination in many countries. The impact of vitamin A capsule supplementation on children's biochemical vitamin A status (serum retinol) in national programs may be less. National data on salt iodization show a consistent relation to reduced prevalence of iodine-deficiency disorder symptoms (goiter); the rates of cretinism and other results of iodine deficiency are almost certainly falling too. The evaluation of the impact of salt iodization programs on biochemical iodine status is limited by a lack of data. Although trials have demonstrated the efficacy of iron supplementation in reducing the prevalence of anemia, the interpretation of national-level data is not so clear. Given the substantial financial and technical commitment required to implement national micronutrient-deficiency control programs, it is vital that investment enable the evaluation of the impact of these programs. It is becoming increasingly important to collect data on subclinical deficiency (e.g., biochemical data) to assess program impact.
在过去10至15年里,微量营养素缺乏控制项目在国家层面得到了极大扩展。然而,对这些项目的严格评估却很稀少,因此关于其影响的结论是初步的,且主要基于间接证据。在大多数研究国家,维生素A胶囊分发项目的覆盖率已超过70%。在实施国家碘盐项目的国家,碘盐供应充足的家庭覆盖率达到60%至90%。在这三种微量营养素中,由于项目监测系统和人口调查数据不足,铁剂补充的覆盖率记录最少。对6至59个月大的学龄前儿童补充维生素A胶囊,很可能有助于减少临床维生素A缺乏症,并在许多国家近乎消除该病症。在国家项目中,维生素A胶囊补充对儿童生化维生素A状态(血清视黄醇)的影响可能较小。国家碘盐数据显示,碘缺乏症症状(甲状腺肿)患病率降低与之存在一致关系;呆小症和其他碘缺乏后果的发生率几乎肯定也在下降。由于缺乏数据,对碘盐项目对生化碘状态影响的评估受到限制。尽管试验已证明铁剂补充在降低贫血患病率方面的有效性,但对国家层面数据的解读并不那么清晰。鉴于实施国家微量营养素缺乏控制项目需要大量资金和技术投入,至关重要的是,投资应能对这些项目的影响进行评估。收集亚临床缺乏数据(如生化数据)以评估项目影响变得越来越重要。